This is a demo store. No orders will be fulfilled.
Immunotherapy Advances across Europe - Genetic Technology TOE
Immunotherapy Advances across Europe - Genetic Technology TOE
18-Nov-2016
Global
Description
This edition of Genetic Technology TOE profiles trends in immunotherapy advances across Europe.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: Immunotherapy, antibody-based discovery, therapeutic targets, systemic lupus erythematosus, enhanced immunogenicity, respiratory syncytial virus vaccine
Table of Contents
Technology Profiles
- Antibody-based Tools for Discovering Novel Therapeutic Targets
- Active Immunotherapy for the Treatment of Systemic Lupus Erythematosus
- Enhancing the Immunogenicity of Respiratory Syncytial Virus Vaccine
- Addressing Media Variability for Vaccine Production
Appendix
- Patent Scenario
- Patent Scenario (continued)
- Industry Interactions
Popular Topics
No Index | No |
---|---|
Podcast | No |
WIP Number | D758-00-2E-00-00 |
Is Prebook | No |
Ti Codes | D758 |